국가: 오스트레일리아
언어: 영어
출처: Department of Health (Therapeutic Goods Administration)
Hologic (Australia & New Zealand) Pty Ltd
Class 2
Hologic Inc 10210 Genetic Center Drive, San Diego, CA, 92121 United States Of America
CT353 - Bacterial infectious disease IVDs
The Aptima? BV assay is an in vitro nucleic acid amplification test that utilizes real time transcription-mediated amplification (TMA) for detection and quantitation of ribosomal RNA from bacteria associated with bacterial vaginosis (BV), including Lactobacillus (L. gasseri, L. crispatus, and L. jensenii), Gardnerella vaginalis, and Atopobium vaginae. The assay reports a qualitative result for BV and does not report results for individual organisms. The assay is intended to aid in the diagnosis of BV on the automated Panther? system using clinician-collected and patient-collected vaginal swab specimens from females with a clinical presentation consistent with vaginitis and/or vaginosis.
A
2019-07-29